We aim to provide something helpful to every employee under Pacific AA Group who are struggling during this crisis period. We are very pleased to present our delightful memories.
Pacific Medical Industries (PMI) is pleased to announce the approval of PACLOVID (Nirmatrelvir 150mg; Ritonavir 100mg) by the Myanmar FDA with recommendation letter no. 2308ND012 for the use of PACLOVID in the mild to moderate coronavirus (COVID-19) in adults.
With the workforce gradually getting back to the office after the pandemic, there are new opportunities and challenges for the L&D managers in the professional space.
Samitivej is proud to announce the launch of our #AcessibleHealthcare Campaign which includes the opening of LONG COVID CENTER to help those previously infected with COVID 19 restore health from the resulting side effects.